Medeologix Inc. announced that it will issue not more than 12,600,000 common shares at an issue price of TWD 25 per share for proceeds of not more than TWD 315,000,000 on January 18, 2024. The transaction will include participation from returning investor Medeon Biodesign, Inc. The transaction was approved by the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.65 TWD | +0.35% | +0.83% | -8.57% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.57% | 120M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- 6499 Stock
- News Medeon Biodesign, Inc.
- Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc.